Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

An Open-labelled, Non-randomized, Multi-centre, Multinational Extension Trial Assessing the Safety of Insulin Aspart in Patients With Type I Diabetes Treated With a Basal-bolus Regimen

NCT00832182 is registered in ClinicalTrials.gov with Novo Nordisk A/S as lead sponsor.

NCT NCT00832182
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00832182 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
An Open-labelled, Non-randomized, Multi-centre, Multinational Extension Trial Assessing the Safety of Insulin Aspart in Patients With Type I Diabetes Treated With a Basal-bolus Regimen
Lead sponsor
Novo Nordisk A/S
Phase
Phase 3
Overall status
Completed
Start date
December 22, 1999
Completion date
November 25, 2002
Enrollment
75 (actual)
Sites
10

Conditions

As the registry lists them; a condition with its own page is linked.

diabetes, diabetes mellitus, type 1